Pages that link to "Q45018959"
Jump to navigation
Jump to search
The following pages link to Serotonin regulates osteoclast differentiation through its transporter (Q45018959):
Displaying 50 items.
- PAMM: a redox regulatory protein that modulates osteoclast differentiation (Q24323917) (← links)
- Relation of serum serotonin levels to bone density and structural parameters in women (Q24620295) (← links)
- An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology (Q25257354) (← links)
- Depression, osteoporosis, serotonin and cell membrane viscosity between biology and philosophical anthropology (Q30401298) (← links)
- Liver regeneration is promoted by increasing serotonin content in rat liver with secondary biliary cirrhosis (Q33395901) (← links)
- The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation (Q33617543) (← links)
- The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5). (Q33635906) (← links)
- Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels (Q33742105) (← links)
- A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys (Q33755068) (← links)
- Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption (Q33789841) (← links)
- Cloning and characterization of osteoclast precursors from the RAW264.7 cell line (Q33906787) (← links)
- Temporomandibular joint bone tissue resorption in patients with early rheumatoid arthritis can be predicted by joint crepitus and plasma glutamate level (Q34022004) (← links)
- Serotonin regulates osteoblast proliferation and function in vitro (Q34083546) (← links)
- Update in Serotonin and Bone (Q34113148) (← links)
- Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics (Q34127450) (← links)
- Minireview: A skeleton in serotonin's closet? (Q34132327) (← links)
- Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis (Q34132829) (← links)
- Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studies (Q34140313) (← links)
- Selective serotonin reuptake inhibitors and the risk of osseointegrated implant failure: a cohort study (Q34418715) (← links)
- Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures? (Q34536565) (← links)
- Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear κB ligand (Q34585204) (← links)
- Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes (Q34956921) (← links)
- The antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model (Q35080134) (← links)
- Spinal cord injury causes rapid osteoclastic resorption and growth plate abnormalities in growing rats (SCI-induced bone loss in growing rats) (Q35207796) (← links)
- A consensus statement for safety monitoring guidelines of treatments for major depressive disorder (Q35311467) (← links)
- The risk of fracture in patients with multiple sclerosis: the UK general practice research database (Q35347484) (← links)
- Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations (Q35490056) (← links)
- Evolutionary molecular medicine (Q35560450) (← links)
- Decreased osteoclastogenesis in serotonin-deficient mice (Q35787005) (← links)
- Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications. (Q35813088) (← links)
- Are selective serotonin reuptake inhibitors a secondary cause of low bone density? (Q35837768) (← links)
- Constitutively Elevated Blood Serotonin Is Associated with Bone Loss and Type 2 Diabetes in Rats. (Q35933172) (← links)
- Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management? (Q36146084) (← links)
- Fluoxetine effects on periodontogenesis: histomorphometrical and immunohistochemical analyses in rats (Q36345013) (← links)
- Brains, bones, and aging: psychotropic medications and bone health among older adults (Q36427958) (← links)
- Expression analysis of nha-oc/NHA2: a novel gene selectively expressed in osteoclasts (Q36503261) (← links)
- Use of antidepressant medications and risk of fracture in older women (Q36526151) (← links)
- Life without peripheral serotonin: insights from tryptophan hydroxylase 1 knockout mice reveal the existence of paracrine/autocrine serotonergic networks. (Q36540919) (← links)
- Depressive symptoms, bone loss, and fractures in postmenopausal women (Q36572715) (← links)
- Age and motor score predict osteoprotegerin level in chronic spinal cord injury (Q36628354) (← links)
- Regulation of bone remodeling by the central and peripheral nervous system (Q36724983) (← links)
- 2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters (Q36776038) (← links)
- The skin as a mirror of the soul: exploring the possible roles of serotonin. (Q37051381) (← links)
- Serotonin: good or bad for bone (Q37056379) (← links)
- Effect of Fluoxetine Consumption on Orthodontic Tooth Movement in Rats (Q37171940) (← links)
- Effects of imatinib and nilotinib on the whole transcriptome of cultured murine osteoblasts (Q37190798) (← links)
- Rates of bone loss among women initiating antidepressant medication use in midlife (Q37275988) (← links)
- Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect. (Q37317822) (← links)
- Use of anti-depressants and the risk of fracture of the hip or femur. (Q37348729) (← links)
- Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS). (Q37392391) (← links)